financetom
Business
financetom
/
Business
/
Enphase Energy to lay off 17% of workforce, take up to $20 mln in charges
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Enphase Energy to lay off 17% of workforce, take up to $20 mln in charges
Nov 9, 2024 1:36 PM

Nov 8 (Reuters) - Enphase Energy ( ENPH ) will cut its

global workforce by about 17%, impacting about 500 employees and

contractors, it said on Friday, as the solar inverter maker

streamlines operations amid slowing residential solar demand.

The company, which has been grappling with a deteriorating

market for residential solar in Europe, will focus contract

manufacturing in four existing locations - two in the US, one in

India and one in China. The company will cease its contract

manufacturing operations in Guadalajara, Mexico, it added.

Enphase's shares have fallen close to 50% so far this year,

with demand for its services weighed down by lower electricity

prices and greater competition in key markets such as the

Netherlands and Germany.

Enphase will incur about $17 million to $20 million in

restructuring and asset impairment charges, of which about $14

million would be in the fourth quarter of 2024. The total cash

expenditures would be about $11 million to $12 million.

The latest move comes after the company unveiled

previous job cuts in December last year, when Enphase said it

would reduce its global workforce by about 10%, impacting about

350 contractors and employees.

"The ongoing challenges from a tough 2023 solar market have

continued to impact us and our industry partners throughout

2024," CEO Badri Kothandaraman said in a message to employees,

which was disclosed in a regulatory filing.

"A combination of factors - including reduced U.S.

residential solar demand due to high interest rates and

declining demand in Europe due to policy changes and utility

rate adjustments - has contributed to sustained unpredictability

in our industry."

Enphase said its adjusted operating expenses in the fourth

quarter are expected to increase as a result of restructuring

plan.

The company expects to reduce its adjusted operating

expenses to a range of $75 million to $80 million a quarter in

2025.

It expects to substantially complete these restructuring

actions by end of the first quarter of 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boeing Lands Fresh 30 Jet Order As Macquarie AirFinance Expands Fleet Ambitions
Boeing Lands Fresh 30 Jet Order As Macquarie AirFinance Expands Fleet Ambitions
Sep 2, 2025
On Tuesday, Boeing Company ( BA ) announced winning an order for 30 737-8 jets from Macquarie AirFinance. The 737-8, recognized for its versatility, seats up to 210 passengers based on configuration and offers a range of 3,500 nautical miles (6,480 km). With this order, Macquarie AirFinance will expand its 737 MAX portfolio to 70, providing its airline customers with access...
High Tide Acquires 51% Stake in Remexian for $30.8 Million
High Tide Acquires 51% Stake in Remexian for $30.8 Million
Sep 2, 2025
06:52 AM EDT, 09/02/2025 (MT Newswires) -- High Tide (HITI) said Tuesday it has acquired a 51% interest in Remexian for about 26.4 million euros ($30.8 million), with the final price to be confirmed within 30 days upon completion of the closing balance sheet. The company said the deal implies a total enterprise valuation of 53.4 million euros. The purchase...
Merck's cholesterol drug meets main goal in late-stage trial
Merck's cholesterol drug meets main goal in late-stage trial
Sep 2, 2025
Sept 2 (Reuters) - Drugmaker Merck said on Tuesday its oral drug met the main goal of reducing bad cholesterol in patients in a late-stage trial. ...
High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH
High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH
Sep 2, 2025
06:51 AM EDT, 09/02/2025 (MT Newswires) -- Cannabis retailer High Tide Inc. ( HITI ) , trading shy of 52 week highs in Canada and the United States, on Tuesday announced that it has completed the acquisition of a 51% interest in Remexian for an estimated purchase price of 26.4 million euros, A statement noted the purchase price will be...
Copyright 2023-2026 - www.financetom.com All Rights Reserved